Status Updates on Neonatal Seizures and Status Epilepticus
- Presenter(s): Deborah Bondi
- Session Length: 90 minutes
- Date: Oct 14, 2025
This session will provide a review of neonatal status epilepticus management, including a comparison between phenobarbital and levetiracetam for first-line management. Literature reviewing the pros and cons of second- and third-line agents will also be reviewed. More novel agents for less common forms of epilepsy will be discussed. (1.5 CEU, 1.5 Pharm)
